These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17408306)

  • 1. Systematic review of piperacillin-induced neutropenia.
    Scheetz MH; McKoy JM; Parada JP; Djulbegovic B; Raisch DW; Yarnold PR; Zagory J; Trifilio S; Jakiche R; Palella F; Kahn A; Chandler K; Bennett CL
    Drug Saf; 2007; 30(4):295-306. PubMed ID: 17408306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
    Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher risk of neutropenia associated with piperacillin-tazobactam compared with ticarcillin-clavulanate in children.
    Lemieux P; Grégoire JP; Thibeault R; Bergeron L
    Clin Infect Dis; 2015 Jan; 60(2):203-7. PubMed ID: 25301207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection.
    Uzun G; Onem Y; Hatipoglu M; Turhan V; Mutluoglu M; Ay H
    Scand J Infect Dis; 2013 Jan; 45(1):73-6. PubMed ID: 22746695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
    Corapcioglu F; Sarper N; Zengin E
    Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects and safety of piperacillin/tazobactam in treating neutropenic febrile patients with malignant hematopathy].
    Lu KY; Jia JS; Li J; Wang C; Wu DP; Hu LD; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):41-4. PubMed ID: 19489243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
    Fouyssac F; Salmon A; Mansuy L; Schmitt C; Bordigoni P; Chastagner P
    Med Mal Infect; 2005 Jun; 35(6):357-62. PubMed ID: 15982848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam.
    Peralta FG; Sánchez MB; Roíz MP; Pena MA; Tejero MA; Arjona R
    Clin Infect Dis; 2003 Dec; 37(11):1568-72. PubMed ID: 14614681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of neutropenia induced by high doses of beta-lactam antibiotics.
    Olaison L; Alestig K
    J Antimicrob Chemother; 1990 Mar; 25(3):449-53. PubMed ID: 2338421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
    Viscoli C; Cometta A; Kern WV; Bock R; Paesmans M; Crokaert F; Glauser MP; Calandra T;
    Clin Microbiol Infect; 2006 Mar; 12(3):212-6. PubMed ID: 16451406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutropenia associated with mezlocillin and piperacillin.
    Kirkwood CF; Lasezkay GM
    Drug Intell Clin Pharm; 1985 Feb; 19(2):112-4. PubMed ID: 3971856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
    Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R
    Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].
    Marie JP; Vekhoff A; Cony-Makhoul P; Fière D; Guy H; Herbrecht R; Milpied N; Pico JL; Plantier I
    Presse Med; 1995 Feb; 24(8):397-401. PubMed ID: 7899419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin-tazobactam as a cost effective monotherapy in febrile neutropenia.
    Fasih S; Siddiqui N; Muza N; Hannan A; Sarwar S; Shafi A; Athar S
    J Ayub Med Coll Abbottabad; 2013; 25(3-4):19-22. PubMed ID: 25226731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
    Zengin E; Sarper N; Kılıç SC
    Pediatr Hematol Oncol; 2011 May; 28(4):311-20. PubMed ID: 21524156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of empirical treatment with piperacillin/tazobactan as monotherapy in episodes of neutropenia and fever in children with cancer: systematic review and meta-analysis].
    Rosanova MT; Cuellar-Pompa L; Lede R
    Rev Chilena Infectol; 2021 Aug; 38(4):488-494. PubMed ID: 34652393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies.
    Hazel DL; Graham J; Dickinson JP; Newland AC; Kelsey SM
    J Chemother; 1997 Aug; 9(4):267-72. PubMed ID: 9269607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tazobactam/piperacillin as an empirical treatment for the patients of adult and child with febrile neutropenia in Japan.
    Tamura K; Akiyama N; Kanda Y; Saito M
    J Infect Chemother; 2015 Sep; 21(9):654-62. PubMed ID: 26141812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.